Clinical And Bacteriological Impact Of Clarithromycin In Streptococcal Pharyngitis: Findings From A Meta-Analysis Of Clinical Trials

References

• Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:e86–102. doi:10.1093/cid/cis62922965026
   PubMed Web of Science ®Google Scholar
• Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2013;(11):CD000023.24190439
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group a streptococcal diseases. Lancet Infect Dis. 2005;5:685–694. doi:10.1016/S1473-3099(05)70267-X16253886
   PubMed Web of Science ®Google Scholar
• Peters DH, Clissold SP. Clarithromycin: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs. 1992;44:117–164. doi:10.2165/00003495-199244010-000091379907
   PubMed Web of Science ®Google Scholar
• Chiappini E, Regoli M, Bonsignori F, et al. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther. 2011;33:48–58. doi:10.1016/j.clinthera.2011.02.00121397773
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Castrellón P, Mayorga-Buitron JL, Bosch-Canto V, Solomon-Santibañez G, de Colsa-Ranero A. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. Rev Invest Clin. 2012;64:126–135.22991774
   PubMedGoogle Scholar
• van Driel ML, De Sutter A, Habraken H, Thorning S, Christiaens T. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst Rev. 2016;9:CD004406.27614728
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.8721797
   PubMedGoogle Scholar
• Schwabe LD, Small MT, Randall EL. Comparison of TestPack Strep A test kit with culture technique for detection of group A streptococci. J Clin Microbiol. 1987;25(2):309–311.3546364
   PubMed Web of Science ®Google Scholar
• Tenjarla G, Kumar A, Dyke JW. TestPack Strep A kit for the rapid detection of group A streptococci on 11,088 throat swabs in a clinical pathology laboratory. Am J Clin Pathol. 1991;96(6):759–761. doi:10.1093/ajcp/96.6.7591746493
   PubMed Web of Science ®Google Scholar
• CLSI.org [homepage on the Internet]. Wayne, PA: CLSI; 2018 Available from: https://clsi.org/ Accessed 1128, 2018.
   Google Scholar
• Bachand RT Jr. A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis. J Antimicrob Chemother. 1991;27(SupplA):75–82. doi:10.1093/jac/27.6.7211827105
   PubMed Web of Science ®Google Scholar
• Abad-Santos F, Gálvez-Múgica MA, Espinosa de Los Monteros MJ, Gallego-Sandín S, Novalbos J. [Meta-analysis of clarithromycin compared with other antimicrobial drugs in the treatment of upper respiratory tract infections]. Rev Esp Quimioter. 2003;16(3):313–324. Spanish.14702124
   PubMedGoogle Scholar
• Blondeau JM, Shebelski SD, Hesje CK. Killing of Streptococcus pneumoniae by azithromycin, clarithromycin, erythromycin, telithromycin and gemifloxacin using drug minimum inhibitory concentrations and mutant prevention concentrations. Int J Antimicrob Agents. 2015;45:594–599. doi:10.1016/j.ijantimicag.2014.08.01425752567
   PubMed Web of Science ®Google Scholar
• Noreddin AM, Roberts D, Nichol K, Wierzbowski A, Hoban DJ, Zhanel GG. Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations. Antimicrob Agents Chemother. 2002;46:4029–4034. doi:10.1128/AAC.46.12.4029-4034.200212435719
   PubMed Web of Science ®Google Scholar
• Kastner U, Guggenbichler JP. Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection. 2001;29:251–256. doi:10.1007/s15010-001-1072-311688901
   PubMed Web of Science ®Google Scholar
• Metzler K, Drlica K, Blondeau JM. Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae. J Antimicrob Chemother. 2013;68:631–635. doi:10.1093/jac/dks46123169894
   PubMed Web of Science ®Google Scholar
• Hoffman HL, Klepser ME, Ernst EJ, Petzold CR, Sa’adah LM, Doern GV. Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model. Antimicrob Agents Chemother. 2003;47:739–746. doi:10.1128/AAC.47.2.739-746.200312543686
   PubMed Web of Science ®Google Scholar
• Karthikeyan G, Guilherme L. Acute rheumatic fever. Lancet. 2018;392:161–174. doi:10.1016/S0140-6736(18)30999-130025809
   PubMed Web of Science ®Google Scholar
• Basyigit I, Yildiz F, Ozkara SK, Yildirim E, Boyaci H, Ilgazli A. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data. Ann Pharmacother. 2004;38:1400–1405. doi:10.1345/aph.1D29515252191
   PubMed Web of Science ®Google Scholar
• Steel HC, Theron AJ, Cockeran R, et al. Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators Inflamm. 2012;2012:584262. doi:10.1155/2012/58426222778497
   PubMed Web of Science ®Google Scholar
• Spyridaki A, Raftogiannis M, Antonopoulou A, et al. Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. Antimicrob Agents Chemother. 2012;56:3819–3825. doi:10.1128/AAC.06446-1122564837
   PubMed Web of Science ®Google Scholar
• Yamaya M, Shinya K, Hatachi Y, et al. Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells. J Pharmacol Exp Ther. 2010;333:81–90. doi:10.1124/jpet.109.16214920040578
   PubMed Web of Science ®Google Scholar
• medicines.org.uk [homepage on the internet]. Clarithromycin 500mg Tablets; 2019 [updated February 23, 2019]. Available from: https://www.medicines.org.uk/emc/product/6094/smpc Accessed 1213, 2018.
   Google Scholar
• Gustafson LW, Blaakær J, Helmig RB. Group A streptococci infection. A systematic clinical review exemplified by cases from an obstetric department. Eur J Obstet Gynecol Reprod Biol. 2017;215:33–40. doi:10.1016/j.ejogrb.2017.05.02028600919
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. doi:10.1038/nrdp.2015.8427188830
   PubMed Web of Science ®Google Scholar
• Hansen MP, Scott AM, McCullough A, et al. Adverse events in people taking macrolide antibiotics versus placebo for any indication. Cochrane Database Syst Rev. 2019;1:CD011825. doi:10.1002/14651858.CD005619.pub330656650
   PubMed Web of Science ®Google Scholar
• O’Doherty B. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group. Eur J Clin Microbiol Infect Dis. 1996;15:718–724. doi:10.1007/bf016919588922571
   PubMed Web of Science ®Google Scholar
• Dhanda V, Chaudhary P, Toor D, Kumar R, Chakraborti A. Antimicrobial susceptibility pattern of β-haemolytic group A, C and G streptococci isolated from North India. J Med Microbiol. 2013;62(Pt 3):386–393. doi:10.1099/jmm.0.046672-023139395
   PubMed Web of Science ®Google Scholar
• Mykhalko YO, Duhovych TV, Kish PP. Susceptibility of streptococcus pneumoniae to fluoroquinolones and macrolides in upper respiratory tract infections. Wiad Lek. 2017;70(2):224–226.28511165
   PubMedGoogle Scholar
• Liu X, Shen X, Chang H, et al. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China. Pediatr Pulmonol. 2009;44(5):436–441. doi:10.1002/ppul.2097619360846
   PubMed Web of Science ®Google Scholar
• Funahashi K, Nakane K, Yasuda N, et al. T serotypes and antimicrobial susceptibilities of group A streptococcus isolates from pediatric pharyngotonsillitis. Jpn J Infect Dis. 2008;61(6):454–456.19050353
   PubMed Web of Science ®Google Scholar
• Sayyahfar S, Fahimzad A, Naddaf A, Tavassoli S. Antibiotic susceptibility evaluation of Group A Streptococcus isolated from children with pharyngitis: a study from Iran. Infect Chemother. 2015;47(4):225–230. doi:10.3947/ic.2015.47.4.22526788405
   PubMedGoogle Scholar
• Sauermann R, Gattringer R, Graninger W, Buxbaum A, Georgopoulos A. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics. J Antimicrob Chemother. 2003;51(1):53–57. doi:10.1093/jac/dkg09712493787
   PubMed Web of Science ®Google Scholar
• Mohan S, Dharamraj K, Dindial R, et al. Physician behaviour for antimicrobial prescribing for paediatric upper respiratory tract infections: a survey in general practice in Trinidad, West Indies. Ann Clin Microbiol Antimicrob. 2004;3:11. doi:10.1186/1476-0711-3-1115196306
   PubMedGoogle Scholar
• Torumkuney D, Zemlickova H, Maruscak M, Morrissey I. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic. J Antimicrob Chemother. 2018;73(Suppl 5):v22–v27. doi:10.1093/jac/dky06729659883
   PubMed Web of Science ®Google Scholar
• Torumkuney D, Papaparaskevas J, Morrissey I. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece. J Antimicrob Chemother. 2018;73(Suppl 5):v36–v42. doi:10.1093/jac/dky06829659884
   PubMed Web of Science ®Google Scholar
• Torumkuney D, Mayanskiy N, Edelstein M, Sidorenko S, Kozhevin R, Morrissey I. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia. J Antimicrob Chemother. 2018;73(Suppl 5):v14–v21. doi:10.1093/jac/dky06529659881
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang F, Wang H, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: results from the CARTIPS Antimicrobial Surveillance Program. J Glob Antimicrob Resist. 2016;5:36–41. doi:10.1016/j.jgar.2016.03.00227436464
   PubMed Web of Science ®Google Scholar